Unclaimed profile: Core Peptides
Get notified about Core Peptides
Get notified when Core Peptides adds new products or coupons.
Explore non-GLP-1 peptides for fat loss research including Fragment 176-191, AOD-9604, Tesamorelin, and CJC-1295/Ipamorelin with mechanisms, research evidence, and pricing.
Read articleComprehensive analysis of AOD-9604 pre-clinical and clinical research: lipolysis mechanism, adipose tissue effects, and comparative growth hormone data.
Read articleSee how this supplier's qualifying offers compare with other active research vendors.
Prices re-checked automatically several times a day · last verified
Core Peptides lists 125 SKUs across 102 products on Peptides.SO, with 75 size-labelled listings at a median of $4.30 per mg. Its list-price range is a narrow $20 to $300. The catalog is growth-peptide led (41 listings), followed by cosmetic peptides (21), bioregulators (17), healing and recovery (11), sexual health (9), research peptides (7), cognitive (7), anti-aging (5), weight management (4) and immune support (3). The supplier's own feed splits the range into 103 single peptides and 18 blends; the blend line (CJC-1295/Ipamorelin, CJC-1295/GHRP-2, and a BPC-157/TB-500/KPV/GHK-Cu combination vial) is the largest of its kind among the suppliers profiled in this batch, and 10 listings carried a discounted price at the last sync.
By category, Core Peptides prices below the platform median on growth peptides ($9.70 vs $12.20 per mg, about 20 percent under), research peptides ($4.60 vs $6.68), healing and recovery ($1.85 vs $4.74) and cosmetic peptides ($0.88 vs $1.00), and is level on bioregulators ($3.15 vs $3.09), sexual health ($4.30 vs $4.50) and cognitive peptides ($6.80 vs $6.73). Only weight management ($7.80 vs $6.50) and immune support ($8.50 vs $7.85) run above.
On the 84 size-labelled products it shares with three or more other suppliers, 23 are priced below the median of the other suppliers and 61 at or above it. The cheapest overlaps are in the secretagogue line: GHRP-6 5mg at $20 against a $33.50 median across 44 other suppliers (40 percent under), CJC-1295 No DAC 5mg at $41 against $57 across 58, PEG-MGF 2mg at $63 against $87 across 5, and the CJC-1295 + GHRP-2 10mg blend at $20 against $27.47 across 12. The premiums sit in a few cosmetic and niche SKUs where Core Peptides' pack size differs from the norm: SNAP-8 10mg at $195 against $40 across 42 suppliers, GHK-Cu 500mg (5 x 100mg) at $197 against $50 across 14, Thymalin 10mg at $138 against $36 across 3, and Gonadorelin 2mg at $90 against $54.81 across 22.
The catalog also carries a receptor-grade IGF-1 LR3 SKU and single-vial AOD-9604, Hexarelin, MOTS-c, Sermorelin and Tesamorelin listings; because several blend rows compute per-mg figures across a multi-compound total, researchers comparing single actives should use the single-peptide listings rather than the blends as the comparison basis.
Verification status: not platform-verified, testing score 0, no Certificate of Analysis on file. Every one of the 170 active suppliers in the directory is in the same position on testing documentation. It holds a 3.7/5 rating from 3 Peptides.SO reviews. Recorded payment methods are Zelle and Cash App; no shipping options are recorded on the platform. Catalog figures come from the supplier's public product feed as last synced by Peptides.SO on 12 March 2026; all 125 listings were in stock at that sync.
All products offered through suppliers listed on Peptides.SO are intended exclusively for in-vitro laboratory research and are not approved, intended, or suitable for human use, animal use, clinical administration, or food production.
15% off site-wide
Deal15OngoingAll products listed are for research purposes only.
112 products · 106 in stock · $20.00 – $240.00 · Anti-Aging & Longevity, Bioregulators, Cognitive & Neuroprotective, Cosmetic & Skin, Growth Peptides, Healing & Recovery, Immune Support, Research Peptides, Sexual Health, Weight Management
Showing 100 of 112 listed products.
A detailed research comparison of BPC-157 (broad regenerative peptide with strong peripheral nerve data) and ARA-290/Cibinetide (IRR agonist with Phase 2 clinical trials in sarcoidosis neuropathy and small fiber neuropathy). Covers mechanisms, evidence hierarchy, and protocol selection for nerve research.

46 shared products